{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:27:09Z","timestamp":1774452429739,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2021YFC2501305"],"award-info":[{"award-number":["2021YFC2501305"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520022"],"award-info":[{"award-number":["Z201100005520022"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520023"],"award-info":[{"award-number":["Z201100005520023"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520025"],"award-info":[{"award-number":["Z201100005520025"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520026"],"award-info":[{"award-number":["Z201100005520026"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520027"],"award-info":[{"award-number":["Z201100005520027"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-013"],"award-info":[{"award-number":["2022-PUMCH-B-013"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-008"],"award-info":[{"award-number":["2022-PUMCH-A-008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40744-023-00610-9","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:02:02Z","timestamp":1698750122000},"page":"1769-1783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome"],"prefix":"10.1007","volume":"10","author":[{"given":"Yuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanting","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangzhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9308-2858","authenticated-orcid":false,"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"issue":"7","key":"610_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530\u20134.","journal-title":"Lupus"},{"key":"610_CR2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 2023;75:1687\u2013702.","journal-title":"Arthritis Rheumatol"},{"key":"610_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.thromres.2020.10.010","volume":"198","author":"Z Sayar","year":"2021","unstructured":"Sayar Z, Moll R, Isenberg D, Cohen H. Thrombotic antiphospholipid syndrome: a practical guide to diagnosis and management. Thromb Res. 2021;198:213\u201321.","journal-title":"Thromb Res"},{"issue":"1","key":"610_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13075-022-02814-w","volume":"24","author":"W Qi","year":"2022","unstructured":"Qi W, Zhao J, Huang C, et al. Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study. Arthritis Res Ther. 2022;24(1):140.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"610_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13075-022-02726-9","volume":"24","author":"AF Guedon","year":"2022","unstructured":"Guedon AF, Catano J, Ricard L, et al. Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study. Arthritis Res Ther. 2022;24(1):33.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"610_CR6","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/art.41891","volume":"73","author":"D Erkan","year":"2021","unstructured":"Erkan D. Expert perspective: management of microvascular and catastrophic antiphospholipid syndrome. Arthritis Rheumatol. 2021;73(10):1780\u201390.","journal-title":"Arthritis Rheumatol"},{"key":"610_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pharmthera.2016.07.015","volume":"167","author":"M Pruenster","year":"2016","unstructured":"Pruenster M, Vogl T, Roth J, Sperandio M. S100A8\/A9: from basic science to clinical application. Pharmacol Ther. 2016;167:120\u201331.","journal-title":"Pharmacol Ther"},{"key":"610_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/828354","author":"A Schiopu","year":"2013","unstructured":"Schiopu A, Cotoi OS. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. Mediators Inflamm. 2013. https:\/\/doi.org\/10.1155\/2013\/828354.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"610_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s11239-020-02324-z","volume":"51","author":"Y Zuo","year":"2021","unstructured":"Zuo Y, Zuo M, Yalavarthi S, et al. Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis. 2021;51(2):446\u201353.","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"610_CR10","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","volume":"133","author":"SP Jackson","year":"2019","unstructured":"Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133(9):906\u201318.","journal-title":"Blood"},{"issue":"1","key":"610_CR11","doi-asserted-by":"publisher","first-page":"100.e8","DOI":"10.1016\/j.chom.2019.05.003","volume":"26","author":"WE Ruff","year":"2019","unstructured":"Ruff WE, Dehner C, Kim WJ, et al. Pathogenic autoreactive T and B cells cross-react with mimotopes expressed by a common human gut commensal to trigger autoimmunity. Cell Host Microbe. 2019;26(1):100\u2013113.e8.","journal-title":"Cell Host Microbe"},{"key":"610_CR12","doi-asserted-by":"publisher","unstructured":"Huang C, Zhao J, Tian X, Wang Q, Xu D, Li M, Zeng X. RheumCloud App: A novel mobile application for the management of rheumatic diseases patients in China. Rheumatol. Immunol. Res. 2022;3(4):184\u201389. https:\/\/doi.org\/10.2478\/rir-2022-0033","DOI":"10.2478\/rir-2022-0033"},{"issue":"2","key":"610_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2478\/rir-2022-0016","volume":"3","author":"H You","year":"2022","unstructured":"You H, Zhao J, Li M, Zeng X. Recurrent non-stroke central neurologic manifestations in primary antiphospholipid syndrome. Rheumatol Immunol Res. 2022;3(2):93\u20134.","journal-title":"Rheumatol Immunol Res"},{"issue":"5","key":"610_CR14","first-page":"1017","volume":"41","author":"C Huang","year":"2023","unstructured":"Huang C, Zhao Y, Tian X, et al. Early recognition of catastrophic antiphospholipid syndrome in patients with antiphospholipid syndrome based on a Chinese cohort study. Clin Exp Rheumatol. 2023;41(5):1017\u201323.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"610_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/09612033211069762","volume":"31","author":"Z Xie","year":"2022","unstructured":"Xie Z, Li H, Qi W, et al. Characteristics and risk factors of retinal vasculopathy in antiphospholipid syndrome. Lupus. 2022;31(2):178\u201386.","journal-title":"Lupus"},{"issue":"7","key":"610_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3899\/jrheum.181241","volume":"46","author":"C Li","year":"2019","unstructured":"Li C, Zhao J, Zhao Y. Hepatic infarction caused by antiphospholipid syndrome secondary to systemic lupus erythematosus. J Rheumatol. 2019;46(7):755\u20136.","journal-title":"J Rheumatol"},{"issue":"11","key":"610_CR17","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1111\/jth.15047","volume":"18","author":"KMJ Devreese","year":"2020","unstructured":"Devreese KMJ, de Groot PG, de Laat B, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost. 2020;18(11):2828\u201339.","journal-title":"J Thromb Haemost"},{"key":"610_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648881","volume":"12","author":"C Hu","year":"2021","unstructured":"Hu C, Li S, Xie Z, et al. Comparison of different test systems for the detection of antiphospholipid antibodies in a Chinese cohort. Front Immunol. 2021;12: 648881.","journal-title":"Front Immunol"},{"issue":"2","key":"610_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295\u2013306.","journal-title":"J Thromb Haemost"},{"issue":"14","key":"610_CR20","doi-asserted-by":"publisher","first-page":"9496","DOI":"10.1074\/jbc.272.14.9496","volume":"272","author":"A Rammes","year":"1997","unstructured":"Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem. 1997;272(14):9496\u2013502.","journal-title":"J Biol Chem"},{"issue":"10","key":"610_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000639","volume":"5","author":"CF Urban","year":"2009","unstructured":"Urban CF, Ermert D, Schmid M, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009;5(10):e1000639.","journal-title":"PLoS Pathog"},{"issue":"1","key":"610_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1189\/jlb.70.1.130","volume":"70","author":"A Voganatsi","year":"2001","unstructured":"Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK. Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol. 2001;70(1):130\u20134.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"610_CR23","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3899\/jrheum.081302","volume":"36","author":"MS Soyfoo","year":"2009","unstructured":"Soyfoo MS, Roth J, Vogl T, Pochet R, Decaux G. Phagocyte-specific S100A8\/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus. J Rheumatol. 2009;36(10):2190\u20134.","journal-title":"J Rheumatol"},{"issue":"24","key":"610_CR24","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1182\/blood.2021014966","volume":"140","author":"M Colicchia","year":"2022","unstructured":"Colicchia M, Schrottmaier WC, Perrella G, et al. S100A8\/A9 drives the formation of procoagulant platelets through GPIbalpha. Blood. 2022;140(24):2626\u201343.","journal-title":"Blood"},{"issue":"4","key":"610_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3748\/wjg.v7.i4.460","volume":"7","author":"JA Tibble","year":"2001","unstructured":"Tibble JA, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol. 2001;7(4):460\u20135.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"610_CR26","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1002\/art.39656","volume":"68","author":"C Lood","year":"2016","unstructured":"Lood C, Tyden H, Gullstrand B, et al. Platelet-derived S100A8\/A9 and cardiovascular disease in systemic lupus erythematosus. Arthritis Rheumatol. 2016;68(8):1970\u201380.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"610_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1056\/NEJMoa1312890","volume":"371","author":"G Canaud","year":"2014","unstructured":"Canaud G, Bienaime F, Tabarin F, et al. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med. 2014;371(4):303\u201312.","journal-title":"N Engl J Med"},{"issue":"15","key":"610_CR28","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","volume":"118","author":"C Agostinis","year":"2011","unstructured":"Agostinis C, Biffi S, Garrovo C, et al. In vivo distribution of beta2 glycoprotein\u00a0I under various pathophysiologic conditions. Blood. 2011;118(15):4231\u20138.","journal-title":"Blood"},{"issue":"3","key":"610_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11926-014-0494-8","volume":"17","author":"B Artim-Esen","year":"2015","unstructured":"Artim-Esen B, Diz-Kucukkaya R, Inanc M. The significance and management of thrombocytopenia in antiphospholipid syndrome. Curr Rheumatol Rep. 2015;17(3):14.","journal-title":"Curr Rheumatol Rep"},{"key":"610_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.101015","volume":"58","author":"G El Hasbani","year":"2023","unstructured":"El Hasbani G, Saliba AN, Uthman I, Taher AT. Hematological manifestations of antiphospholipid syndrome: going beyond thrombosis. Blood Rev. 2023;58:101015.","journal-title":"Blood Rev"},{"issue":"8","key":"610_CR31","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1002\/art.21968","volume":"54","author":"T Shi","year":"2006","unstructured":"Shi T, Giannakopoulos B, Yan X, et al. Anti-beta2-glycoprotein\u00a0I antibodies in complex with beta2-glycoprotein\u00a0I can activate platelets in a dysregulated manner via glycoprotein\u00a0Ib-IX-V. Arthritis Rheum. 2006;54(8):2558\u201367.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"610_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semarthrit.2017.12.006","volume":"48","author":"M Radin","year":"2018","unstructured":"Radin M, Ugolini-Lopes MR, Sciascia S, Andrade D. Extra-criteria manifestations of antiphospholipid syndrome: risk assessment and management. Semin Arthritis Rheum. 2018;48(1):117\u201320.","journal-title":"Semin Arthritis Rheum"},{"issue":"18","key":"610_CR33","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/CM9.0000000000002128","volume":"135","author":"C Huang","year":"2022","unstructured":"Huang C, Hu C, Zhao J, et al. Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored. Chin Med J (Engl). 2022;135(18):2251\u20132.","journal-title":"Chin Med J (Engl)"},{"issue":"13","key":"610_CR34","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1177\/0961203319882506","volume":"28","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhao J, Zhang P, et al. Clinical characteristics and risk factors of microvascular involvement in primary antiphospholipid syndrome: a longitudinal single-center study in China. Lupus. 2019;28(13):1558\u201365.","journal-title":"Lupus"},{"key":"610_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102813","volume":"128","author":"MG Tektonidou","year":"2022","unstructured":"Tektonidou MG. Cardiovascular disease risk in antiphospholipid syndrome: thrombo-inflammation and atherothrombosis. J Autoimmun. 2022;128:102813.","journal-title":"J Autoimmun"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-023-00610-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-023-00610-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-023-00610-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T16:42:45Z","timestamp":1700152965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-023-00610-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1007\/s40744-023-00610-9","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yuan Zhao, Wanting Qi, Can Huang, Yangzhong Zhou, Qian Wang, Xinping Tian, Mengtao Li, Yan Zhao, Xiaofeng Zeng and Jiuliang Zhao have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Medical Ethics Committee of Peking Union Medical College Hospital (approval number: JS-2038) and carried out in accordance with the Declaration of Helsinki and its later amendments. Written informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}